169.80
Praxis Precision Medicines Inc Borsa (PRAX) Ultime notizie
Praxis Precision Medicines Stock (PRAX) Opinions on Short Report Controversy - Quiver Quantitative
Praxis Precision Medicines general counsel sells $4.8m in shares - Investing.com
Praxis Precision Medicines exec sells $2.6m in shares - Investing.com
Praxis Precision Medicines exec sells $2.6m in shares By Investing.com - Investing.com India
Is Praxis Precision Medicines Inc. stock near bottom after declineJuly 2025 Price Swings & Reliable Momentum Entry Alerts - newser.com
Praxis Precision Medicines to Participate in Upcoming Fireside Chat - The Manila Times
Praxis Precision Medicines (NASDAQ: PRAX) to Discuss Ulixacaltamide Data on Nov. 24 Call - Stock Titan
Short Seller Alleges Praxis Precision's Potential $3 Billion Drug 'A House Of Cards' - Benzinga
Praxis Precision Medicines (PRAX) Faces Challenges as Culper Res - GuruFocus
Praxis Precision Medicines drops after Culper Research short call (PRAX:NASDAQ) - Seeking Alpha
Praxis Precision Medicines stock falls after Culper short report By Investing.com - Investing.com Canada
Culper Research says we are short Praxis Precision Medicines Inc - MarketScreener
Is Praxis Precision Medicines Inc. stock supported by strong fundamentalsWeekly Profit Report & Fast Gain Stock Tips - newser.com
How analysts rate Praxis Precision Medicines Inc. stock todayTrend Reversal & Accurate Intraday Trade Tips - newser.com
Praxis a new buy at BTIG as biotech is a top pick for 2026 - Seeking Alpha
Is Praxis Precision Medicines Inc. stock a contrarian buyWeekly Stock Report & Weekly Breakout Opportunity Watchlist - newser.com
BTIG Research Initiates Coverage on Praxis Precision Medicines With Buy Rating, $424 Price Target - MarketScreener
BTIG Initiates Coverage of Praxis Precision Medicines (PRAX) with Buy Recommendation - Nasdaq
Using fundamentals and technicals on Praxis Precision Medicines Inc.July 2025 Selloffs & Technical Entry and Exit Alerts - newser.com
BTIG Initiates Coverage on PRAX with Buy Rating and $424 Price T - GuruFocus
Published on: 2025-11-19 03:37:53 - newser.com
Applying big data sentiment scoring on Praxis Precision Medicines Inc.Quarterly Investment Review & Daily Stock Trend Reports - newser.com
Commit To Purchase Praxis Precision Medicines At $100, Earn 27.5% Using Options - Nasdaq
Praxis Precision Medicines (PRAX) Price Target Increased by 11.27% to 287.79 - Nasdaq
What valuation multiples suggest for Praxis Precision Medicines Inc. stockIPO Watch & Entry Point Strategy Guides - newser.com
Can Praxis Precision Medicines Inc. stock deliver surprise earnings beatWeekly Profit Summary & Low Risk High Win Rate Picks - newser.com
Certain Stock Options of Praxis Precision Medicines, Inc. are subject to a Lock-Up Agreement Ending on 16-NOV-2025. - MarketScreener
How institutional buying supports Praxis Precision Medicines Inc. stockPortfolio Update Summary & AI Powered Trade Plan Recommendations - newser.com
Published on: 2025-11-15 06:25:23 - newser.com
What institutional flow reveals about Praxis Precision Medicines Inc.2025 Technical Patterns & Expert Approved Momentum Ideas - newser.com
HC Wainwright & Co. Maintains Praxis Precision Medicines (PRAX) Buy Recommendation - Nasdaq
Using Python tools to backtest Praxis Precision Medicines Inc. strategiesMarket Growth Summary & Weekly Setup with High ROI Potential - newser.com
PRAX: HC Wainwright & Co. Raises Price Target to $258 | PRAX Sto - GuruFocus
Published on: 2025-11-12 17:26:58 - newser.com
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):